| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 07/12/2007 | CA2635580A1 Substituted bis-amide metalloprotease inhibitors |
| 07/12/2007 | CA2634989A1 Antibody molecules specific for fibroblast activation protein and immunoconjugates containing them |
| 07/11/2007 | EP1806365A1 Antibody molecules specific for fibroblast activation protein and immunoconjugates containing them |
| 07/11/2007 | EP1806338A1 Process for producing 2-amino-2-[2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl[ethyl]-1,3-propanediol hydrochloride or hydrate thereof and intermediate for the same |
| 07/11/2007 | EP1806144A2 Use of SARP-1 for the treatment and/or prevention of scleroderma |
| 07/11/2007 | EP1458706B1 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 07/11/2007 | EP1408961B1 2 pyrrolidone derivatives as prostanoid agonists |
| 07/11/2007 | EP1366021B1 Substituted diarylureas as stimulators for fas-mediated apoptosis |
| 07/11/2007 | EP1105467B1 USE OF MODIFIED LYSOZYME c TO PREPARE MEDICINAL COMPOSITIONS FOR THE TREATMENT OF SOME SERIOUS DISEASES |
| 07/11/2007 | EP1028945B1 Substituted pyridine compounds as anti-inflammatory agents |
| 07/11/2007 | CN1997645A Immunomodulating oxopyrrazolocinnolines as CD80 inhibitors |
| 07/11/2007 | CN1997425A Canine osteoarthritis diet formulation |
| 07/11/2007 | CN1997375A Transdermal steroid formulation |
| 07/11/2007 | CN1995039A Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 07/11/2007 | CN1994998A 4-methyl cyclopentadecanone and its uses |
| 07/11/2007 | CN1994441A Pain-relieving oral liquid with nut-vomitive posonnut seed for treating cervical and lumbar disease |
| 07/11/2007 | CN1994431A Medicament for treating protrusion of ntervertebral disc and hyperosteogeny and preparation process thereof |
| 07/11/2007 | CN1994430A Externally applied ointment for activating blood circulation and unblocking obstruction |
| 07/11/2007 | CN1994428A Chinese medicine for treating ischemic necrosis of femoral head |
| 07/11/2007 | CN1994410A Bone-setting Chinese medicinal capsule for treating bone fracture |
| 07/11/2007 | CN1994401A Chinese medicinal capsule for treating joint pain and hyperosteogeny |
| 07/11/2007 | CN1994395A Chinese medicinal formulation for treating prolapse of intervertebral disc |
| 07/11/2007 | CN1994392A Compound drynaria capsule and tablet and preparation method thereof |
| 07/11/2007 | CN1994380A Externally applied medicine for treating arthritis, hot pack and preparation method thereof |
| 07/11/2007 | CN1994358A Chinese medicinal formulation for treating rheumatic and rheumatoid arthritis and preparation process thereof |
| 07/11/2007 | CN1994351A Yeradetajo extract, its preparation method and use |
| 07/11/2007 | CN1994298A Carbamate aspartic acid specific cysteine proteinase inhibitors and uses thereof |
| 07/11/2007 | CN1994140A Paste with fleece-flower root and sesame for reducing fat, protecting liver and preventing against osteoprosis |
| 07/11/2007 | CN1325651C High-efficiency expression and application of human recombinant interferon B |
| 07/11/2007 | CN1325506C Allan phosphonic acid as bone re-absorption inhibitor and its physiologically acceptable salt and their prepn |
| 07/11/2007 | CN1325498C Novel crystalline compound |
| 07/11/2007 | CN1325497C Pharmaceutically active isoindoline derivs. |
| 07/11/2007 | CN1325491C Novel crystals |
| 07/11/2007 | CN1325480C Novel phenylalanine derivatives |
| 07/11/2007 | CN1325479C Pyrimidine compounds |
| 07/11/2007 | CN1325110C Medicated wine for treating traumatic injury |
| 07/11/2007 | CN1325070C Chinese traditional medicine Tripterygium wilfordii and improving technique for attenuation and synergy of its extract |
| 07/11/2007 | CN1325063C L-amino acid water-soluble pearl powder and its preparing method |
| 07/11/2007 | CN1325062C Method for obtaining binded estrogen mixture from pregnant horse urine, and its uses of big pore adsorption resin in the method |
| 07/11/2007 | CN1325058C Application of sodium selenite in preparation of medicine for treating wind, dampness and cold caused arthralgia |
| 07/10/2007 | USRE39723 Semi-synthetic taxanes with antitumor and antiangiogenetic activities |
| 07/10/2007 | US7241873 Recombinant anti-osteopontin antibody and use thereof |
| 07/10/2007 | US7241869 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 07/10/2007 | US7241860 Transcription factor polypeptide that regulates Chondromodulin-I expression |
| 07/10/2007 | US7241791 Substituted 4-(indazol-3-yl)phenols |
| 07/10/2007 | US7241789 Substituted indoles and their use as integrin antagonists |
| 07/10/2007 | US7241781 Thiazolyl inhibitors of Tec family tyrosine kinases |
| 07/10/2007 | US7241777 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors |
| 07/10/2007 | US7241763 3-furanyl analogs of toxoflavine as kinase inhibitors |
| 07/10/2007 | US7241758 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases |
| 07/10/2007 | US7241755 E.g., pentamethyl-16-[1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-1-aza-13(Z)-cyclohexadecene-2,6-dione and 4S-[4R*,7S*,8R*,9R*,15R*(E)]]-4,8-dihydroxy-5,5,7,9,13,16-hexamethyl-16-[1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-1-oxa-13-cyclohexadecene-2,6-dione; antiproliferative agents |
| 07/10/2007 | US7241747 For therapy and prophylaxis of diseases where bone formation is desired, such as osteoporosis, as well as autoimmune diseases such as multiple sclerosis, diabetes mellitus and lupus; also exhibit pronounced activity in arresting the proliferation of undifferentiated cells |
| 07/10/2007 | US7241739 Contacting Bone Morphogenic Protein with human Cerberus protein to antagonize the function of a Bone Moarphogenic Protein or induce neural development |
| 07/10/2007 | US7241738 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/10/2007 | US7241733 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses |
| 07/10/2007 | US7241619 Identification of genes encoding enzymes (Thraustochytrium aureum Delta 5-desaturase, Saprolegnia diclina Delta 5-desaturase, Saprolegnia diclina Delta 6-desaturase)involved in synthesis of polyunsaturated fatty acids |
| 07/10/2007 | US7241576 Applications of a novel cytokine, named THANK, for TNF homologue that activates apoptosis, NF- kappa B and c-jun N-terminal kinase. Such applications include using THANK inhibitors to inhibit the activation of NF-kappa B and to |
| 07/10/2007 | CA2194462C Hard tissue stimulating agent |
| 07/05/2007 | WO2007074916A1 3,4-dihydrobenzoxazine compound and inhibitor of vanilloid receptor type 1 (vr1) activity |
| 07/05/2007 | WO2007074859A1 Anti-c-mannosylated peptide antibody and use thereof |
| 07/05/2007 | WO2007074753A1 Pharmaceutical comprising substituted urea derivative |
| 07/05/2007 | WO2007073921A1 Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acid |
| 07/05/2007 | WO2007073661A1 Activated collagen scaffold materials and their special fused active restoration factors |
| 07/05/2007 | WO2007056433A3 Methods of treating tissue defects |
| 07/05/2007 | WO2007017050A8 Method for isolating stem cells and stem cells derived from a pad-like tissue of teeth |
| 07/05/2007 | US20070157326 Ee3-protein family and corresponding dna sequence |
| 07/05/2007 | US20070155808 G Protein-Coupled Receptors (GPR40); insulin secretagogue; diabetes; 3-[4-[[4-[[(2-Phenylethyl)(4-phenyl-1,3-thiazol-2-yl)amino]methyl]benzyl]oxy]phenyl]propanoic acid |
| 07/05/2007 | US20070155804 Mitotic kinesin inhibitor |
| 07/05/2007 | US20070155762 Treating atherosclerosis by administering 1-(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)-2-(4-fluorobenzyl)thio-5,6-trimethylenepyrimidin-4-one or a salt; coadministering an anticholesterol agent; inhibitor of platlet activating factor acetylhydrolase |
| 07/05/2007 | US20070155756 Treatment of chemokine mediated diseases |
| 07/05/2007 | US20070155734 Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 07/05/2007 | US20070155732 Aryl or Heteroaryl Fused Imidazole Compounds as Anti-Inflammatory and Analgesic Agents |
| 07/05/2007 | US20070155724 Methods of Treating Cytokine Mediated Diseases |
| 07/05/2007 | US20070155713 Nitrogen-containing heterocyclic compounds and use thereof |
| 07/05/2007 | US20070155671 e.g. N-[2-chloro-4-[[[(3-hydroxyphenyl)methyl]amino]carbonyl]benzoyl]-3-(phenylmethyl)amino-L-alanine; intercellular adhesion molecules blocking agent; antiinflammatory; reperfusion injury following acute myocardial infarction |
| 07/05/2007 | US20070155652 Composition for regenerative treatment of cartilage disease |
| 07/05/2007 | US20070154912 87 Human Secreted Proteins |
| 07/05/2007 | US20070154556 Injectable gel-type bone-repairing material and preparing method thereof |
| 07/05/2007 | US20070154540 Composition for treatment of osteoarthritis containing apigenin as chondroregenerative agent |
| 07/05/2007 | US20070154401 Compositions and methods for enhanced mucosal delivery of parathyroid hormone |
| 07/05/2007 | US20070154400 Compositions and methods for enhanced mucosal delivery of parathyroid hormone |
| 07/05/2007 | CA2646974A1 Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acid |
| 07/05/2007 | CA2632508A1 3,4-dihydrobenzoxazine compound and inhibitor of vanilloid receptor type 1 (vr1) activity |
| 07/04/2007 | EP1804062A2 YKL-40 as a marker and prognostic indicator for cancers |
| 07/04/2007 | EP1803811A1 Chimeric (double) decoy |
| 07/04/2007 | EP1803810A1 Integrin antagonists |
| 07/04/2007 | EP1803730A1 Albumin fusion proteins |
| 07/04/2007 | EP1803729A1 1-( -d-glycopyranosyl)-3-substituted nitrogenous heterocyclic compound, medicinal composition containing the same, and medicinal use thereof |
| 07/04/2007 | EP1803466A1 Treatment of chronic joint inflammation by an anti-CD3 antibody |
| 07/04/2007 | EP1803451A1 Pufa supplements |
| 07/04/2007 | EP1802660A2 Methods of using death receptor ligands and cd20 antibodies |
| 07/04/2007 | EP1802626A1 Pyrrolotriazine compounds |
| 07/04/2007 | EP1802618A1 Biphenyl integrin antagonists |
| 07/04/2007 | EP1802612A1 Novel b1 bradykinin receptor antagonists |
| 07/04/2007 | EP1802590A1 Substituted n-alkylpyrimidinones |
| 07/04/2007 | EP1802325A2 Crig polypeptide for prevention and treatment of complement-associated disorders |
| 07/04/2007 | EP1802291A2 Calixarene-based peptide conformation mimetics, methods of use, and methods of making |
| 07/04/2007 | EP1423143A4 Crystal forms and mutants of rank ligand |
| 07/04/2007 | EP1339411B1 Use of zoledronic acid for pain treatment |
| 07/04/2007 | EP1286690B1 Use of alpha-msh and epo for the manufacture of a medicament for preventing or treating ischemic conditions |